Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 24;61(2):e02342-16.
doi: 10.1128/AAC.02342-16. Print 2017 Feb.

Missense Mutations in the Unfoldase ClpC1 of the Caseinolytic Protease Complex Are Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis

Affiliations

Missense Mutations in the Unfoldase ClpC1 of the Caseinolytic Protease Complex Are Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis

Michelle Yee et al. Antimicrob Agents Chemother. .

Abstract

Previously, we showed that mutations in Mycobacterium tuberculosis panD, involved in coenzyme A biosynthesis, cause resistance against pyrazinoic acid, the bioactive component of the prodrug pyrazinamide. To identify additional resistance mechanisms, we isolated mutants resistant against pyrazinoic acid and subjected panD wild-type strains to whole-genome sequencing. Eight of the nine resistant strains harbored missense mutations in the unfoldase ClpC1 associated with the caseinolytic protease complex.

Keywords: ClpC1; Mycobacterium tuberculosis; caseinolytic protease; pyrazinamide; resistance.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Characterization of pyrazinoic acid (POA)-resistant panD wild-type M. tuberculosis strains. Growth inhibition dose-response curves of 9 POA-resistant panD wild-type strains, POAr 11 to 19, POA-sensitive wild-type M. tuberculosis H37Rv, and a representative POA-resistant panD mutant strain, POAr 1, isolated previously (14), for (A) POA, (B) rifampin (RIF), and (C) isoniazid (INH). Experiments were carried out 3 times independently with technical replicates. Mean values and standard deviations from results of representative experiments are shown. (D) Location of 7 ClpC1 amino acid sequence polymorphisms in POA-resistant panD wild-type M. tuberculosis strains POAr 12 to 19. ClpC1 domain organization is shown as described in reference . Within the N-terminal domain, two repeats are labeled I and II. A and B in the D1 and D2 domains indicate Walker A and Walker B motifs, respectively. (E) Location of the nucleotide sequence polymorphism G to C (−10) in the untranslated leader mRNA of clpC1 in POA-resistant panD wild-type M. tuberculosis strain POAr 11. The organization of the clpC1 upstream region is shown as described in reference . A conserved TANNNT promoter motif (TACAGT) and the transcriptional start site (TSS), located 55 bp upstream of the clpC1 coding sequence, are indicated (20). Refer to Table 1 for genotypes and phenotypes of strains.

References

    1. Mitchison DA. 1985. The action of antituberculosis drugs in short-course chemotherapy. Tubercle 66:219–225. doi: 10.1016/0041-3879(85)90040-6. - DOI - PubMed
    1. Zumla AI, Gillespie SH, Hoelscher M, Philips PPJ, Cole ST, Abubakar I, McHugh TD, Schito M, Maeurer M, Nunn AJ. 2014. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. Lancet Infect Dis 14:327–340. doi: 10.1016/S1473-3099(13)70328-1. - DOI - PubMed
    1. Zhang Y, Shi W, Zhang W, Mitchison D. 2013. Mechanisms of pyrazinamide action and resistance. Microbiol Spectr 2:1–12. doi: 10.1128/microbiolspec.MGM2-0023-2013. - DOI - PMC - PubMed
    1. Via LE, Savic R, Weiner DM, Zimmerman MD, Prideaux B, Irwin SM, Lyon E, O'Brien P, Gopal P, Eum S, Lee M, Lanoix J-P, Dutta NK, Shim T, Cho JS, Kim W, Karakousis PC, Lenaerts A, Nuermberger E, Barry CE, Dartois V. 2015. Host-mediated bioactivation of pyrazinamide: implications for efficacy, resistance, and therapeutic alternatives. ACS Infect Dis 1:203–214. doi: 10.1021/id500028m. - DOI - PMC - PubMed
    1. Scorpio A, Zhang Y. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 2:662–667. doi: 10.1038/nm0696-662. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources